Health Care · Health Care Equipment

LivaNova PLC LIVN

$82.09+1.51 (+1.87%)delayed quote · as of 2026-07-29 06:39 UTC

Open LIVN in the workspaceCharts, statements, and the evidence behind every figure — free to start.

Market cap

$4.5B

Previous close

$80.58

Volume

530K

52-week range

$41.02 – $85.27

Verdictconfidence 100% · high

Growth, Health and Momentum stand out; value flashes caution.

4 of 5 dimensions score well; value flashes caution.

Value402/5 checks

Growth804/5 checks

Quality603/5 checks

Health1005/5 checks

Momentum1005/5 checks

Fair-value estimate $54.98 per share (2-stage FCF · individual beta · 10Y Rf 4.7%) — the price sits 49% above it.

Every check behind these scores — with its numbers, source, and evidence link — is in the workspace. Free account required.

Key ratioslatest filing FY 2025

Value

P/E TTM

41.9

P/E FWD

17.7

EV/EBITDA TTM

16.1

PEG

0.78

FCF yield FY2025

3.8%

Growth

Revenue 3y

+10.8%/yr

Revenue YoY

+10.7%

Expected EPS

+136.4%

Quality

Piotroski F

4 / 9

ROIC

113.3%

Gross margin

67.7%

Health

Altman Z

2.23

Current ratio

1.36

Debt/equity

0.31

Momentum

vs 50-day

+26.6%

vs 200-day

+43.5%

52-wk range

93%

FY 2025: revenue $1.4B · net income -$242.5M · free cash flow $173.3M (SEC EDGAR filings)

ALAN GLOBAL INTELLIGENCE · alanglobalintelligence.comquote as of 2026-07-29 06:39 UTC · fundamentals FY 2025 · SEC EDGAR

Verdict

Reading LIVN’s filed statements…

Continue with LIVN in ALAN

Full evidence trail, financial statements back a decade, valuation history, charts, and alerts.

Open in the workspace Create free account

For information and research only. Not investment advice. ALAN does not place trades or execute orders. Figures come from the sources shown and can lag the market; verify independently before making decisions. Past performance is not predictive of future results.